… , multivessel coronary artery disease on coronary angiography, … , contemporary,
population-based cohort study of patients … Given that patients who underwent coronary artery …

… -dose versus standard-dose clopidogrel regimens in these patients, we found no evidence
of … (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients …

… with peripheral artery disease to treatment with ticagrelor 90 mg twice daily … patients with
a history of limb revascularization is a representative cohort of patients treated in contemporary …

… the contemporary understanding … use of DAPT with clopidogrel 75 mg daily plus aspirin
75–162 mg daily versus aspirin alone in 15,603 patients with either established vascular disease …

… -up rate, this study provides very high-quality, long-term, contemporary, clinical trial-based
information regarding clinical and subclinical outcomes of coronary artery bypass grafting. …

… Inhibition) program, where it was compared with different clopidogrel regimens, and it is
currently indicated for use in patients with coronary artery disease undergoing percutaneous …

… coronary artery disease (CAD), peripheral arterial disease (PAD), and cerebrovascular disease
… ) or documented atherosclerotic cardiovascular disease (78%) to clopidogrel 75 mg daily …

… Age and comorbidities for HBR patients treated during the CP and TP were similar except
for a more frequent diagnosis of peripheral artery disease during the CP (16.3% vs. 7.0%, p = …

… This study sought to compare clinical outcomes in a contemporary acute coronary
syndrome (ACS) percutaneous coronary intervention (PCI) cohort stratified by chronic kidney …

… Dose bridging between clopidogrel … in patients switching from clopidogrel to ticagrelor,
while the bridging between ticagrelor MD and clopidogrel MD was more likely to occur in patients …